申请人:Yoshitomi Pharmaceutical Industries, Ltd.
公开号:US05712274A1
公开(公告)日:1998-01-27
Thienotriazolodiazepine compounds of the formula (1) ##STR1## wherein each symbol is as defined in the specification, pharmaceutically acceptable salts thereof, and pharmaceutical use thereof. The compounds of the present invention are useful as preventive and therapeutic drugs for inflammatory diseases and allergic diseases, in which cell adhesion is involved.
Thienotriazolodiazepine化合物的化学式(1)##STR1##其中每个符号如规范中定义,其药用盐,以及其药用。本发明的化合物可用作预防和治疗细胞黏附参与的炎症性疾病和过敏疾病的药物。